These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25972284)

  • 1. The Impact of Oral Intake of Dydrogesterone on Fetal Heart Development During Early Pregnancy.
    Zaqout M; Aslem E; Abuqamar M; Abughazza O; Panzer J; De Wolf D
    Pediatr Cardiol; 2015 Oct; 36(7):1483-8. PubMed ID: 25972284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dydrogesterone support in threatened miscarriage.
    El-Zibdeh MY; Yousef LT
    Maturitas; 2009 Dec; 65 Suppl 1():S43-6. PubMed ID: 20007011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dydrogesterone use during pregnancy: overview of birth defects reported since 1977.
    Queisser-Luft A
    Early Hum Dev; 2009 Jun; 85(6):375-7. PubMed ID: 19193503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dydrogesterone in the reduction of recurrent spontaneous abortion.
    El-Zibdeh MY
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):431-4. PubMed ID: 16253504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dydrogesterone in threatened miscarriage: a Malaysian experience.
    Pandian RU
    Maturitas; 2009 Dec; 65 Suppl 1():S47-50. PubMed ID: 20005647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal smoking and congenital heart defects.
    Malik S; Cleves MA; Honein MA; Romitti PA; Botto LD; Yang S; Hobbs CA;
    Pediatrics; 2008 Apr; 121(4):e810-6. PubMed ID: 18381510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental pathologic conditions in anticardiolipin antibody positive women whose infants had congenital heart defects.
    Kowal-Vern A; Fisher SG; Muraskas J; Jandreski MA; Gianopoulos JG; Husain A
    J Perinatol; 1996; 16(4):268-71. PubMed ID: 8866295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital heart disease in the offspring and maternal habits and home exposures during pregnancy.
    Tikkanen J; Heinonen OP
    Teratology; 1992 Nov; 46(5):447-54. PubMed ID: 1462249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence of congenital defects in the children of mothers who used medications in the first trimester of pregnancy in the Czech Republic 1996-2001].
    Sípek A; Gregor V; Velebil P; Horácek J; Masátová D; Svĕtnicová K
    Ceska Gynekol; 2003 Nov; 68(6):401-19. PubMed ID: 15042851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal use of bupropion and risk for congenital heart defects.
    Alwan S; Reefhuis J; Botto LD; Rasmussen SA; Correa A; Friedman JM;
    Am J Obstet Gynecol; 2010 Jul; 203(1):52.e1-6. PubMed ID: 20417496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between maternal alcohol use and smoking in early pregnancy and congenital cardiac defects.
    Mateja WA; Nelson DB; Kroelinger CD; Ruzek S; Segal J
    J Womens Health (Larchmt); 2012 Jan; 21(1):26-34. PubMed ID: 21895513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal febrile illnesses, medication use, and the risk of congenital renal anomalies.
    Abe K; Honein MA; Moore CA
    Birth Defects Res A Clin Mol Teratol; 2003 Nov; 67(11):911-8. PubMed ID: 14745928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors in congenital heart disease.
    Roodpeyma S; Kamali Z; Afshar F; Naraghi S
    Clin Pediatr (Phila); 2002; 41(9):653-8. PubMed ID: 12462314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subchorionic hemorrhage treatment with dydrogesterone.
    Pelinescu-Onciul D
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():77-81. PubMed ID: 17943544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion in pregnancy and the prevalence of congenital malformations.
    Cole JA; Modell JG; Haight BR; Cosmatos IS; Stoler JM; Walker AM
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):474-84. PubMed ID: 16897811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid monotherapy in pregnancy and major congenital malformations.
    Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT;
    N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal obesity and infant heart defects.
    Cedergren MI; Källén BA
    Obes Res; 2003 Sep; 11(9):1065-71. PubMed ID: 12972676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal water consumption during pregnancy and congenital cardiac anomalies.
    Shaw GM; Swan SH; Harris JA; Malcoe LH
    Epidemiology; 1990 May; 1(3):206-11. PubMed ID: 2081254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newer-generation antiepileptic drugs and the risk of major birth defects.
    Mølgaard-Nielsen D; Hviid A
    JAMA; 2011 May; 305(19):1996-2002. PubMed ID: 21586715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors for the development of congenital heart defects in children born in the Tuzla Canton].
    Begić H; Tahirović HF; Dinarević S; Ferković V; Pranjić N
    Med Arh; 2002; 56(2):73-7. PubMed ID: 12014099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.